Abstract
OBJECTIVE Guidance of patients treated with antidepressants is paramount for successful therapy. The aim was to assess patients' needs and suggestions for improvement of guidance by physicians and pharmacists during second generation antidepressant (SGA) therapy. DESIGN Five focus group discussions were held with a total of 34 patients using an SGA. METHODS The discussions were conducted flexibly and responsrvely using a semistructured topic list. All focus group discussions were video-recorded and transcripts were analysed using ATLAS.ti for coding, thematic and open analysis. RESULTS Participants stated they were in need of better guidance. They suggested improving content of information during decisional moments, patient-health care professional communication and communication in-between health care professionals, and finally, organisation of guidance. Barriers to achieving improved guidance were cited. CONCLUSION Content, communication and organisation of guidance are pivotal for achieving optimal guidance. Participants mentioned that their current experienced guidance had limitations and brought up solutions for improvement. A next step would be to discuss the suggested solutions with health care professionals to assess their views and to discuss the possibility for implementation. After implementation, future studies could be aimed at determination of its impact on patients' treatment efficacy, quality of life, treatment satisfaction and healthcare costs.
Translated title of the contribution | Guidance by physicians and pharmacists during antidepressant therapy: patients' needs and suggestions for improvement |
---|---|
Original language | Dutch |
Pages (from-to) | 25-27 |
Number of pages | 3 |
Journal | Pharmaceutisch Weekblad |
Volume | 153 |
Issue number | 46 |
Publication status | Published - 16 Nov 2018 |